For years, metformin has been the go-to first-line oral medication for patients newly diagnosed with type 2 diabetes. But ...

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

The landmark achievement in diabetes research in the country could potentially transform how certain rare forms of the ...

High blood pressure frequently occurs in people with diabetes. Learn about the relationship, risks, and treatments for ...

In summary, this study shows that for women with type 2 diabetes who were diagnosed with high blood pressure before age 50, ...

Researchers from the Karolinska Institutet in Sweden have found a potential new treatment for non-alcoholic fatty liver ...

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by a common condition.

treatment, and long-term disease management for thousands of individuals living with undetected or misclassified forms of monogenic diabetes. Colin G. Nichols, lead researcher, Washington ...

Diagnosing chronic kidney disease and getting treatment early can play a significant role in helping to improve outcomes. For people with type 1 and type 2 diabetes, annual screenings for ...

More and more companies are investing in developing GLP-1R agonists, including dual and triple agonists and combination ...

This reduction in treatment costs is expected to help manage the increasing prevalence of the disease. This announcement was made during the 10th Annual Kenya Diabetes Study Group (KDSG ...